Guru Ownership Trend
Guru Analysis for Arrowhead Pharmaceuticals, Inc. (ARWR)
Arrowhead Pharmaceuticals, Inc. (ARWR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $183.7 M.
Top institutional holders include Ken Fisher and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $54.89 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Joel Greenblatt reduced exposure by 32.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Arrowhead Pharmaceuticals, Inc. (ARWR)
Major holders include Ken Fisher ($69.82 M), Renaissance Technologies (RenTech) ($64.99 M), Cliff Asness ($10.33 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.45 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $54.89 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited ARWR. The total reported sell value was $13.56 M.
Yes, 1 managers opened new positions in ARWR, and 2 increased their existing holdings. The total reported buy value was $68.45 M.